- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01918436
RCT, Proof of Concept Study of TEAMS (Training Executive, Attention and Motor Skills) Intervention Program (TEAMS)
TEAMS (Training Executive, Attention, and Motor Skills): - Intervention Program for Preschoolers With ADHD (Attention Deficit Hyperactivity Disorder). A Rct. Proof-of-Concept Study.
Background:
TEAMS (Training Executive Attention and Motor Skills) is a non-pharmacological, neurocognitive intervention program targeted preschool children with ADHD developed by Professor Jeffrey Halperin, and his team from New York University. The uniqueness of this program lies in the concept, based on stimulating neurocognitive growth through focused physical activity and play (Halperin et al.; 2011, 2012, in press).
Teams hypotheses:
TEAMS is based on the notions that:
- The behavioural manifestations of ADHD are the result of deficient neural networks that affect a wide array of neurocognitive and behavioural processes which are not necessarily identical in all children with the disorder.
- Neurodevelopment is sensitive to and can be positively affected by appropriate environmental influences.
- Effective environmental stimulation will be best achieved within a social context.
- The engagement of the child in the core activities of the treatment must be intrinsically rewarding (i.e., fun) in order to facilitate compliance of the intervention.
The initial research by Halperin et al. (2012)indicated significant improvement in ADHD severity from pre- to post-treatment, which also persisted 3 months later.
Objective: The aim of this study is, through a randomized controlled trial (RCT), to validate the TEAMS treatment program in a clinical setting in Denmark.
Method: Pre-school children age 3-6, from Region Zealand in Denmark, diagnosed with ADHD as primary diagnosis are offered participation in the RCT study of the TEAMS program. The control groups receive the standard treatment program, outlined by the clinical guidelines of Region Zealand. The intervention groups participate in eight weekly group sessions consisting of separate parent- and children's groups.
In the child group the children are introduced to games that are designed to enhance inhibitory control, working memory, attention, visuospatial abilities, planning, and motor skills. The parent group consists of psychoeducation and instructions in how to encourage playing these games with their children and how to support the child's development.
Study Overview
Status
Intervention / Treatment
Detailed Description
Based on a calculation of strength:
Concurring to a statistically significant outcome the estimated cohort should be minimum 87 children. Based on Region Zealand's visitation history records the cohort is expected to be approximately 100-160 children.
Group size:
The number of participants in each treatment group depends in part on how many children have been recruited. Given the constraints of our setting, treatment groups generally consist of at least two, and up to five participants.
Staffing: Two group leaders and one student-assistant are present for every five participants in the playgroup.
For the primary efficiency measurements the project uses: ADHD-RS-IV (Attention Deficit Hyperactivity Disorder Rating Scale fourth edition), a scale for evaluating the severity of the ADHD symptoms, SDQ-DAN (Strengths and Difficulties Questionnaire - Danish translation) focuses upon the child's strengths and weaknesses in accordance with activity and attention, emotional problems, behavioural difficulties etc. For the secondary efficiency measurements the project uses: TCA (Treatment Compliance Assessment) (Halperin et al: in press), which establishes how much time the child spends on each TEAMS activity and television/computer games each day. Each day the parents fill out the TCA, as part of a logbook which also describes compliance with the TEAMS treatment project.
The questionnaires are continuously catalogued in a database facility (SurveyXact).
The TCA instrument is completed weekly during the 8 week TEAMS program.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Holbaek, Denmark, 4300
- Recruiting
- Boerne- og Ungdomspsykiatrisk afdeling, Region Sjaelland
-
Contact:
- Helle A. Vibholm, MSc,Ns.spec.
- Phone Number: +45 59 48 47 30
- Email: hevi@regionsjaelland.dk
-
Principal Investigator:
- Jesper Petersen, MD,Phd.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Children age 3-6, diagnosed with ADHD as primary diagnosis
Exclusion Criteria:
- Children of parents, who are not capable of cooperating in order to implement the program.
- Children living at residential institution or in an unstable environment outside the home.
- Children or parents, who do not speak/understand Danish Children, who are in medical treatment for ADHD.
- Children with significant disabilities due to comorbidity, such as autism, attachment disorder or mental retardation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: TEAMS intervention
Pre-school children age 3-6, from Region Zealand in Denmark, diagnosed with ADHD as primary diagnosis are offered participation in the RCT study of the TEAMS program. The intervention groups participate in eight weekly group sessions consisting of separate parent- and children's groups. In the child group, the children are introduced to games that are designed to enhance inhibitory control, working memory, attention, visuospatial abilities, planning, and motor skills. The parent group consists of psychoeducation and instructions in how to encourage playing these games with their children and how to support the child's development. |
In the child group the children are introduced to games that are designed to enhance inhibitory control, working memory, attention, visuospatial abilities, planning, and motor skills.
The parent group consists of psychoeducation and instructions in how to encourage playing these games with their children and how to support the child's development.
|
ACTIVE_COMPARATOR: Control group
The control groups receive the standard treatment program, outlined by the clinical guidelines of Region Zealand, Denmark.
|
The control groups receive the standard treatment program, outlined by the clinical guidelines of Region Zealand, Denmark.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in ADHD (Attention Deficit Hyperactivity Disorder) core symptoms: measured by ADHD-RS IV: 'Attention Deficit Hyperactivity Disorder- symptom rating scale (teacher and parent rated.)
Time Frame: 1 month, 3 months, 6 months
|
1 month, 3 months, 6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Compliance with TEAMS program (TCA: Treatment Compliance Assessment)(parent rated)
Time Frame: paticipants will be followed for the duration of the 8 week intervention
|
paticipants will be followed for the duration of the 8 week intervention
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in Behavioural screening questionnaire SDQ-DAN (Strengths and Difficulties Questionnaires - DANISH translation)(parent and teacher rated)
Time Frame: 1 month, 3 months, 6 months
|
1 month, 3 months, 6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Jesper Pedersed, MD,PH.D, Psychiatric Hospital Roskilde: Denmark
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SJ-331
- RESUS (OTHER_GRANT: Region Zealand Psychiatric Research Unit)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on ADHD
-
The Hong Kong Polytechnic UniversityRecruiting
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)Recruiting
-
VIZO Specs LtdRecruiting
-
Loewenstein HospitalWingate InstituteRecruiting
-
Florida State UniversityRecruiting
-
Florida International UniversityRecruiting
-
Region Örebro CountyRecruiting
-
Johns Hopkins UniversityWithdrawn
-
Tris Pharma, Inc.Premier Research Group plcCompleted
Clinical Trials on TEAMS intervention
-
Emory UniversityCompleted
-
Ryerson UniversityCanadian Institutes of Health Research (CIHR); Trillium Health CentreCompletedDiabetes Mellitus
-
US Department of Veterans AffairsCompleted
-
University of IowaNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Center for Research to PracticeUnknown
-
University of California, DavisNational Institute of Mental Health (NIMH); University of California, San Diego and other collaboratorsEnrolling by invitationAutism Spectrum DisorderUnited States
-
Royal Cornwall Hospitals TrustCompletedHead and Neck NeoplasmsUnited Kingdom
-
University of California, IrvineUniversity of Maryland, Baltimore CountyNot yet recruitingSuicide | Psychosis | Health Care Utilization | Family Members
-
University of RochesterUniversity of Rhode IslandCompleted
-
University of PennsylvaniaNational Institute on Aging (NIA)Completed